期刊文献+

建立动物心衰模型的方法及意义 被引量:14

下载PDF
导出
摘要 心力衰竭是各种心脏结构或功能性疾病导致心室充盈或射血能力受损而引起的一组综合征,临床表现主要是呼吸困难和无力而致体力活动受限和水肿。目前,心力衰竭已成为全球主要致死原因之一。据世界卫生组织公布的资料,目前全球心衰患者的数量已高达2250万以上,仍以每年200万的速度递增。在我国,根据中华医学会心血管病学分会估算,我国成年人心衰的患病率为0.9%,其中男性为0.7%,女性为1.0%,目前35~74岁成年人中约有400万的心衰患者,并呈逐年上升趋势。在现有的医学措施干预下,大约仍有50%的患者会在5年内出现严重并发症,危及生命。心力衰竭患者5年病死率男性达75%,女性达42%,与癌症患者5年病死率相近。由于心衰的发病率与病死率较高,且尚无特别理想的解决办法,这就需要建立更好的实验模型,以了解疾病进程及研究新的治疗方法。一个心衰模型不可能完美重现疾病的各个方面,所以亟待解决建立理想的急、慢性心衰模型,以研究不同的病理过程。目前建立心衰模型主要有容量超负荷、压力超负荷、快速起搏、心肌梗死及药物毒性等方法,为总结各种心衰模型的建立方法及各自为疾病认识所做的贡献,综述如下。
作者 耿阳 刘学刚
出处 《中华全科医学》 2014年第2期282-285,共4页 Chinese Journal of General Practice
  • 相关文献

参考文献22

  • 1沈秀云.心力衰竭的最新临床进展[J].海南医学,2009,20(S5):289-292. 被引量:5
  • 2Seqqat R, Guo X, Rafiq K, et al. Betal-adrenergic receptors promote focal adhesion signaling downregulation and myocyte apoptosis in acute volume overload [ J ]. Journal of molecular and cellular cardiology, 2012,53 ( 2 ) : 240 -249.
  • 3Leroux AA, Moonen ML, Pierard L, et al. Animal models of mitral re-gurgitation induced by mitral valve chordae tendineae rupture[ J]. The Journal of heart valve disease,2012,21 (4) :416-423.
  • 4Martin TP, Robinson E, Harvey AP, et al. Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice [ J ]. Experimental physiology, 2012,97 ( 7 ) : 822-832.
  • 5Brooks WW, Shen SS, Conrad CH, et al. Transition from compensated hypertrophy to systolic heart failure in the spontaneously hypertensive rat : Structure, function, and transcript analysis [ J ]. Genomics ,2010,95 (2) :84-92.
  • 6Lux RL, Gettes LS. Repolarization heterogeneity and rate dependency in a canine rapid pacing model of heart failure[ J]. Journal of electro- cardiology,2011,44 (6) :730-735.
  • 7Rademaker MT, Charles C J, Nicholls MG, et al. Haemodynamic, endo- crine and renal actions of adrenomedullin 5 in an ovine model of heart failure [ J ]. Clinical science ( London, England : 1979 ) ,2012,122 ( 9 ) : 429-437.
  • 8Chelladurai P, Seeger W, Pullamsetti SS, et al. Matrix metalloproteinas- es and their inhibitors in pulmonary hypertension [ J ]. The European respiratory journal ,2012,40 ( 3 ) :766-782.
  • 9Takagaki M, McCarthy PM,Tabata T, et al. Induction and maintenance of an experimental model of severe cardiomyopathy with a novel proto- col of rapid ventricular pacing[ J]. The Joamal of thoracic and cardio- vascular surgery,2002,123 ( 3 ) :544-549.
  • 10Salikova SP, Bakhtiiarov RZ. The role of structural changes of the en- dothelium and myocardium in the development of experimental heart failure [ J ]. Morfologiia ( Saint Petersburg, Russia), 2008,134 ( 5 ) : 20 -25.

二级参考文献19

  • 1杨建业,张迎春,王明江,唐俊明,汤敏,王家宁.大鼠左冠状动脉不同结扎时间对心肌梗死面积及心功能的影响[J].郧阳医学院学报,2006,25(2):74-77. 被引量:12
  • 2张健,窦克非,杨跃进,韦丙奇,宋蓉,李佳,郑昕.静脉注射β受体阻滞剂治疗缺血性心脏病慢性心力衰竭急性加重临床经验总结[J].中国循环杂志,2006,21(3):175-177. 被引量:22
  • 3范慧敏,卢蓉,李健,郭建华,刘泳,刘中民.机械辅助循环在治疗心力衰竭患者中的作用[J].中华急诊医学杂志,2007,16(3):302-305. 被引量:6
  • 4郑斯聚.新型正性肌力药——左西孟旦[J].国际麻醉学与复苏杂志,2007,28(2):118-121. 被引量:1
  • 5Lopez S J, Swedbert K, McMurray J, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J, 2004,25 ( 15 ) : 1341-1362.
  • 6Mariell Jessup, Donald E. Casey, Arthur M. Feldman, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation, 2009, 119 :e391-e479.
  • 7Sallach JA, Goldstein S. Use of beta-blockers in congestive heart failure. Ann Med,2003,35(4) : 259-66.
  • 8Domanski MJ, Krause-Steinrauf H, Massie BM,et al. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-Ⅱ, MERIT-HF, and COPERNICUS. J Card Fail,2003 Oct; 9(5) :354-63.
  • 9Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J, 2006 Oct;27(19) :2257-9.
  • 10Graq R, Yusf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA, 1995 May 10 ;273 ( 18 ) : 1450-1456.

共引文献31

同被引文献184

引证文献14

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部